$Mind Medicine (MindMed) Inc.(MNMD)$The company is in its early stages of developing drugs that could potentially make waves. It has an impressive patent portfolio which includes26 pendingU.S. patent applications. Its lead candidate isMM-120, a formulation of LSD that has considerably improved safety and efficacy in recent results.
Investing in a pre-revenue company comes with a ton of risk, but with MNMD, it’s not without healthy upside.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments